By Michael Balsamo and Zeke Miller

A person in California who had been vaccinated against COVID-19 became the first in the U.S. to have an identified case of the omicron variant, the White House announced Wednesday as scientists continue to study the risks posed by the new virus strain.

Dr. Anthony Fauci told reporters the person was a traveler who returned from South Africa on Nov. 22 and tested positive on Nov. 29. Fauci said the person was vaccinated but had not received a booster shot and was experiencing “mild symptoms.”

The Biden administration moved late last month to restrict travel from Southern Africa where the variant was first identified and had been widespread. Clusters of cases have also been identified in about two dozen other nations.

“We knew that it was just a matter of time before the first case of omicron would be detected in the United States,” Fauci said.

He said the person was improving and added, “I think what’s happening now is another example of why it’s important for people to get vaccinated. But also boosting. Boosting is very important.”

Officials said they had contacted everyone who had close contact with the person and they had all tested negative.

Genomic sequencing was conducted at the University of California, San Francisco and the sequence was confirmed by the Centers for Disease Control and Prevention.

The Centers for Disease Control and Prevention is taking steps to tighten U.S. testing rules for travelers from overseas, including requiring a test for all travelers within a day of boarding a flight to the U.S. regardless of vaccination status. It was also considering mandating post-arrival testing.

Officials said those measures would only “buy time” for the country to learn more about the new variant and to take appropriate precautions, but that given its transmissibility its arrival in the U.S. was inevitable.

Much remains unknown about the new variant, including whether it is more contagious than previous strains, whether it makes people more seriously ill, and whether it can thwart the vaccine. Fauci, the top U.S. infectious disease expert, said more would be known about the omicron strain in two to four weeks as scientists grow and test lab samples of the virus.

California’s Department of Public Health credited the state’s “large-scale testing and early detection systems” for identifying the case.

“We recognize that everyone is exhausted, and the news of a new variant can be overwhelming. It is important that we collectively focus on the things we know prevent the spread of COVID-19, and its variants,” state public health officials said in a statement.

The announcement of the first U.S. case comes before President Joe Biden plans to outline his strategy on Thursday to combat the virus over the winter. Biden has tried to quell alarm over the omicron variant, saying it was a cause for concern but “not a cause for panic.”

Biden and public health officials have grown more urgent in their pleas for more Americans to get vaccinated — and for those who have been vaccinated to get booster shots to maximize their protection against the virus.

Updated on December 1, 2021, at 3:45 p.m. ET with the latest details.

Share:
More In Science
FDA Panel Recommends Pfizer Vaccine for Kids Ages 5-11
An FDA panel has recommended the low-dose Pfizer vaccine for kids ages five to 11. The recommendation now cues up the FDA to authorize the vaccine. Next week, the CDC will consider its own authorization. Once signed off by the CDC, the Pfizer vaccine can be administered in children immediately. Dr. Christina Johns, Senior Medical Advisor at PM Pediatrics, joined Cheddar's Search for a Cure.
A Look Ahead at G20 Summit and COP26 on Addressing the Climate Crisis
World leaders will converge this weekend at the 2021 G20 Summit in Rome and the UN COP26 conference in Glasgow with the climate crisis on the agenda. Lord Adair Turner, chair of the Energy Transitions Commission, joined Cheddar to discuss what people can expect to come out of the climate-focused conferences. Turner also noted that one of the biggest hurdles for the attending nations will be coming to a uniform decision on expanding on the Paris Climate Accord goals that have become insufficient to prevent global warming by 1.5 degrees celsius.
Expanding Genetic Testing for Women Everywhere
Nicole Lambert, President at Myriad Genetics joins ChedHER to discuss how to expand access to genetic testing for all women, and how her experience as a 'pre-vivor' motivates her role in the industry.
Proptech Startup Juno Raises $20 Million
Proptech startup Juno recently raised $20 million in a Series A funding round. The company says the funds will be used to further its mission of building sustainable and affordable apartment buildings across the United States. Juno Co-Founder and CEO Jonathan Sherr joined Cheddar News' Closing Bell to discuss.
Innovation in Breast Cancer Screening
Stacey Stevens, President of iCAD, joins 'Cheddar Innovates' to discuss how 'Profound A.I. Risk' works as a short-term breast cancer risk estimation for women.
Merck to Offer Poorer Countries COVID-19 Pill Formula for Free
Pharmaceutical company Merck has announced that it will share the formula of its COVID-19 pill with poor countries free of charge. The company still intends to charge wealthier nations leaving the end cost at more than $700 per five-day treatment course.
Deal or No Deal, ISIS Threat & Memecoin Insanity
Dems race for a deal on President Biden's economic agenda ahead of his big foreign trip. What to make of the latest threat assessment in Afghanistan. Plus, the meme cryptocurrency of the moment that's now worth more than many Fortune 500 companies.
Load More